Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer
Although chemotherapy, targeted therapy and endocrine therapy decrease rate of disease recurrence in most breast cancer patients, many patients exhibit acquired resistance. Hyperactivation of the PI3K/AKT/mTOR pathway is associated with drug resistance and cancer progression. Currently, a number of...
Saved in:
Main Authors: | Chao Dong (Author), Jiao Wu (Author), Yin Chen (Author), Jianyun Nie (Author), Ceshi Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren's Syndrome
by: Ping Zeng, et al.
Published: (2022) -
Calcium Dobesilate Restores Autophagy by Inhibiting the VEGF/PI3K/AKT/mTOR Signaling Pathway
by: Yue Wang, et al.
Published: (2019) -
Downregulation of PI3K/AKT/mTOR Pathway in Juglone-Treated Bovine Oocytes
by: Marwa El-Sheikh, et al.
Published: (2023) -
The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
by: Amin Iranpanah, et al.
Published: (2023) -
Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021)